Morris M Eisen, DO in Voorhees, NJ - Medicare Thoracic Surgery (Cardiothoracic Vascular Surgery)

Morris M Eisen, DO is a medicare enrolled "Thoracic Surgery (cardiothoracic Vascular Surgery)" physician in Voorhees, New Jersey. His current practice location is 2301 E Evesham Rd, Suite 406, Voorhees, New Jersey. You can reach out to his office (for appointments etc.) via phone at (856) 772-9600.

Morris M Eisen is licensed to practice in New Jersey (license number MB38543) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1558326579.

Contact Information

	Morris M Eisen, DO
	2301 E Evesham Rd, Suite 406, Voorhees, NJ 08043-4501
	(856) 772-9600
	(856) 772-9650

Physician's Profile

Full Name	Morris M Eisen
Gender	Male
Speciality	Thoracic Surgery (cardiothoracic Vascular Surgery)
Location	2301 E Evesham Rd, Voorhees, New Jersey
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1558326579
Provider Enumeration Date: 04/20/2006
Last Update Date: 11/24/2008

Medicare PECOS Information:

PECOS PAC ID: 2961315304
Enrollment ID: I20050815000843

Medical Identifiers

Medical identifiers for Morris M Eisen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558326579	NPI	-	NPPES
P00633440	Other	NJ	RAILROAD MEDICARE
3911101	Medicaid	NJ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208G00000X	Thoracic Surgery (cardiothoracic Vascular Surgery)	MB38543 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Morris M Eisen is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Morris M Eisen, DO 114 Morningside Dr, Cherry Hill, NJ 08003-1022 Ph: (856) 772-9600	Morris M Eisen, DO 2301 E Evesham Rd, Suite 406, Voorhees, NJ 08043-4501 Ph: (856) 772-9600

News Archive

CHI submits comments to FDA CDRH 510(k) Working Group Preliminary Report and Recommendations

California Healthcare Institute today submitted formal comments to the U.S. Food and Drug Administration (FDA) regarding the Center for Devices and Radiological Health 510(k) Working Group Preliminary Report and Recommendations, which could transform the 510(k) regulatory process for new medical devices, greatly affecting innovation and public health in California. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.

US Task Force recommends lung-cancer screening for high-risk adults

High-risk adults between the ages of 55 and 80 should receive annual lung cancer screening with low-dose computed tomography, according to final recommendations from the U.S. Preventive Services Task Force being published in Annals of Internal Medicine.

Harris Health System to help HHS improve critical cyber infrastructure of healthcare sector

Harris Health System is the only healthcare system in the nation awarded a $150,000 grant to help the U.S. Department of Health and Human Services (HHS) develop and improve ways to share cybersecurity threat information and protect the critical cyber infrastructure of the nation's public and private healthcare sector.

SQream Technologies releases GenomeStack platform for genome research

SQream Technologies, provider of the world's fastest big data analytics database, today announced the release of GenomeStack, its latest innovative platform developed specifically for genome research.

Stereotactic body radiotherapy appears to be safe, effective for some pancreatic cancer patients

Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread.

Morris M Eisen, DO - Medicare Thoracic Surgery (Cardiothoracic Vascular Surgery) in Voorhees, NJ